These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 14668616

  • 1. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
    Haralambous E, Hibberd ML, Hermans PW, Ninis N, Nadel S, Levin M.
    Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
    [Abstract] [Full Text] [Related]

  • 2. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
    Geishofer G, Binder A, Müller M, Zöhrer B, Resch B, Müller W, Faber J, Finn A, Endler G, Mannhalter C, Zenz W, Central European Meningococcal Genetic Study Group.
    Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
    [Abstract] [Full Text] [Related]

  • 3. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.
    Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M.
    Lancet; 1999 Aug 14; 354(9178):556-60. PubMed ID: 10470700
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A, Villagrán A, Vollrath V, Hanckes P, Salas R, Farah A, Solís N, Pizarro M, Escalona A, Boza C, Pérez G, Carrasco G, Padilla O, Miquel JF, Nervi F, Chavez-Tapia NC, Arab JP, Alvarez-Lobos M, Arrese M, Riquelme A.
    Ann Hepatol; 2011 Aug 14; 10(4):493-501. PubMed ID: 21911891
    [Abstract] [Full Text] [Related]

  • 5. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.
    Westendorp RG, Hottenga JJ, Slagboom PE.
    Lancet; 1999 Aug 14; 354(9178):561-3. PubMed ID: 10470701
    [Abstract] [Full Text] [Related]

  • 6. 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia.
    Binder A, Endler G, Müller M, Mannhalter C, Zenz W, European Meningococcal Study Group.
    J Thromb Haemost; 2007 Oct 14; 5(10):2049-54. PubMed ID: 17697137
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction.
    Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M.
    Coron Artery Dis; 2013 May 14; 24(3):196-200. PubMed ID: 23283030
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological significance of plasminogen activator inhibitor-1 promoter 4G/5G polymorphism in breast cancer: a meta-analysis.
    Lee JH, Kim Y, Choi JW, Kim YS.
    Arch Med Res; 2013 Jan 14; 44(1):39-45. PubMed ID: 23291383
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.
    Berberoğlu M, Evliyaoğlu O, Adiyaman P, Ocal G, Ulukol B, Simşek F, Siklar Z, Törel A, Ozel D, Akar N.
    J Pediatr Endocrinol Metab; 2006 May 14; 19(5):741-8. PubMed ID: 16789641
    [Abstract] [Full Text] [Related]

  • 10. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
    Seguí R, Estellés A, Mira Y, España F, Villa P, Falcó C, Vayá A, Grancha S, Ferrando F, Aznar J.
    Br J Haematol; 2000 Oct 14; 111(1):122-8. PubMed ID: 11091191
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor-1 4G/5G polymorphism and susceptibility to endometriosis in the Italian population.
    Gentilini D, Vigano P, Castaldi D, Mari D, Busacca M, Vercellini P, Somigliana E, di Blasio AM.
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct 14; 146(2):219-21. PubMed ID: 19608328
    [Abstract] [Full Text] [Related]

  • 12. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A, D'Agostino R, Rich SS, Jenny NS, Tracy RP, Haffner SM.
    Circulation; 2003 May 20; 107(19):2422-7. PubMed ID: 12719278
    [Abstract] [Full Text] [Related]

  • 13. In meningococcal disease 4G bad, 5G good.
    Baines PB, Carrol ED.
    Crit Care Med; 2003 Dec 20; 31(12):2813-4. PubMed ID: 14668625
    [No Abstract] [Full Text] [Related]

  • 14. 4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.
    Yende S, Angus DC, Ding J, Newman AB, Kellum JA, Li R, Ferrell RE, Zmuda J, Kritchevsky SB, Harris TB, Garcia M, Yaffe K, Wunderink RG, Health ABC Study.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1129-37. PubMed ID: 17761618
    [Abstract] [Full Text] [Related]

  • 15. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C, Ozdemir Koroglu Z, Kurt H, Yanas M, Colak E, Degirmenci I, Gunes HV.
    J Clin Pharm Ther; 2017 Feb 01; 42(1):103-107. PubMed ID: 27796029
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY.
    PLoS One; 2012 Feb 01; 7(4):e33511. PubMed ID: 22496752
    [Abstract] [Full Text] [Related]

  • 17. The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.
    Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R.
    Eur J Haematol; 2001 Jan 01; 66(1):57-62. PubMed ID: 11168509
    [Abstract] [Full Text] [Related]

  • 18. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome.
    Muetze S, Eggermann T, Leeners B, Birke C, Kuse S, Ortlepp JR, Rudnik-Schoeneborn S, Zerres K, Rath W.
    J Thromb Thrombolysis; 2009 Feb 01; 27(2):141-5. PubMed ID: 18058192
    [Abstract] [Full Text] [Related]

  • 19. The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.
    Jones K, Powell J, Brown L, Greenhalgh R, Jormsjö S, Eriksson P.
    Eur J Vasc Endovasc Surg; 2002 May 01; 23(5):421-5. PubMed ID: 12027469
    [Abstract] [Full Text] [Related]

  • 20. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan 01; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.